Antidepressant, neuropharmacological activity and mode of action of theaflavin-3-gallate in in vitro and in vivo models of depression

Ying Wang, Jing Chen, Jing Wang, Xin Guo, Ning Wang, Yuan JieBangladesh 2018 · DOI

Abstract

This study investigates the antidepressant-like effect of theaflavin-3-gallate (TF3G), a plant polyphenolic compound, in 1-methyl-4-phenyl pyridinium (MPP+)-induced neuronal injury in N2a cells and in vivo mouse models. Results from MTT and lactic dehydrogenase (LDH) assays revealed that TF3G exerted a significant neuroprotective effect. Treatment with TF3G increased cell viability from 23.3% to 79.6% and decreased LDH leakage from 63.2 to 23.4 U/L. Furthermore, TF3G reduced intracellular $Ca^{2+}$ overloading and induced neurite outgrowth in injured N2a cells. In vivo, TF3G significantly reduced immobility time in both the forced swimming test and tail suspension test, suggesting potent antidepressant-like activity.

Introduction

Major Depressive Disorder (MDD) is a global health crisis, yet current pharmacological treatments—like SSRIs—often come with significant side effects and limited efficacy for many patients. Recent research has pivoted toward "neuroplasticity," the idea that depression is linked to the physical shrinking or death of neurons in specific brain regions. This paper explores the potential of theaflavin-3-gallate (TF3G), a polyphenolic compound found in black tea, to act as a neuroprotective and antidepressant agent. The authors address the need for plant-derived compounds that can protect and repair the brain's physical structure rather than just balancing neurotransmitters.

Methods

The study employed a two-pronged approach:

  1. In Vitro (Cell Culture): Mouse neuroblastoma (N2a) cells were exposed to MPP+, a neurotoxin that mimics cellular stress seen in depression. Researchers measured cell viability (MTT assay), cell damage (LDH leakage), calcium signaling (Fura-2 assay), and neurite outgrowth via inverted phase microscopy.
  2. In Vivo (Animal Models): Male rodents were treated with TF3G and subjected to behavioral tests including the Forced Swimming Test (FST), Tail Suspension Test (TST), and Open Field Test (OFT) to measure behavioral despair and general locomotion.

Results

Neuroprotection and Calcium Regulation

One of the most critical findings was that TF3G provides dose-dependent protection against neurotoxicity. As the concentration of TF3G increased, cell viability rose from a dismal 23.3% in the toxin-only group to a robust 79.6% at the highest dose.

Cell viability of N2a cells treated with MPP+ and varying doses of theaflavin-3-gallate.

Additionally, TF3G significantly mitigated intracellular calcium overloading. In stressed neurons, excessive calcium acts as a "death signal"; TF3G slashed these levels from 842.2 nmol/L to approximately 410.6 nmol/L, preventing programmed cell death.

Structural Repair and Behavioral Impact

Beyond mere survival, TF3G promoted neurite outgrowth, helping damaged neurons regrow the connections (axons and dendrites) necessary for communication. This suggests that the compound enhances brain plasticity rather than just preventing damage.

Inverted phase microscopy showing the effect of theaflavin-3-gallate on neurite outgrowth in N2a cells.

In behavioral trials, TF3G performed comparably to the standard antidepressant fluoxetine (Prozac). It significantly decreased immobility time in mice during the FST and TST, indicating a reduction in behavioral despair. The Open Field Test confirmed these results were due to mood improvement rather than general stimulant effects.

Conclusion

Theaflavin-3-gallate demonstrates potent neuroprotective and antidepressant-like effects by regulating calcium signaling and promoting structural neuroplasticity. While promising, future work is needed to map the exact molecular signaling pathways and overcome the low bioavailability typically associated with dietary polyphenols before clinical translation can occur.

Summary updated

Abstract

Herein the antidepressant-like effect of theaflavin-3-gallate, a plant polyphenolic compound in 1-methyl-4-phenyl pyridinium-induced neuronal injury in N2a cells used as an in vitro model of depression as well as in vivo. The results from MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) and lactic dehydrogenase assay revealed that theaflavin-3-gallate exerted a neuroprotective effect in N2a cells. Treatments with mixtures of 1-methyl-4-phenyl pyridinium (20 µM) and four concentration levels of theaflavin-3-gallate increased cell viability from 23.3 to 79.6% while lactic dehydrogenase leakage value decreased from 63.2 to 23.4 U/L. Fura-2-acetoxymethyl ester assay for Ca2+ concentration measurement revealed that different doses of theaflavin-3-gallate or fluoxetine (20 µM) reduced the intracellular Ca2+ overloading in N2a cells induced by 1-methyl-4-phenyl pyridinium. Inverted phase microscopy showed that theaflavin-3-gallate induced neurite outgrowth in 1-methyl-4-phenyl pyridinium-induced neurotoxicity in N2a cells. Theaflavin-3-gallate could significantly reduce the immobility time of mice in both forced swimming test and tail suspension test. Video Clip of Methodology: MTT Assay: 3 min 38 sec Click to watch
BibTeX
@inproceedings{wang2018antidepressant,
  author = {Ying Wang and Jing Chen and Jing Wang and Xin Guo and Ning Wang and Yuan Jie},
  title = {{Antidepressant, neuropharmacological activity and mode of action of theaflavin-3-gallate in in vitro and in vivo models of depression}},
  booktitle = {Bangladesh},
  year = {2018},
  doi = {10.3329/bjp.v13i4.37773},
}
Figure